Key result
Catheter ablation for drug-refractory paroxysmal atrial fibrillation achieved a single-procedure success rate of 58.7% and a multiprocedure success rate of 86.9% at 12 years.
Why the study?
Does catheter ablation provide long-term success in patients with drug-refractory paroxysmal atrial fibrillation?
Population
513 patients with drug-refractory paroxysmal atrial fibrillation (PAF)
Design
Editorial
Follow-up
12 years
Authors
Loading...
Catheter ablation for drug-refractory paroxysmal atrial fibrillation provides a high multiprocedure success rate of 86.9% over a 12-year follow-up, though single-procedure success is modest at 58.7%.
Cohort (n=513)
Does catheter ablation provide long-term success in patients with drug-refractory paroxysmal atrial fibrillation?
Catheter ablation for drug-refractory paroxysmal atrial fibrillation provides a high multiprocedure success rate of 86.9% over a 12-year follow-up, though single-procedure success is modest at 58.7%.
Kumar et al. (2016) conducted a cohort in Paroxysmal Atrial Fibrillation (n=513). Catheter ablation was evaluated on Single-procedure success rate. Catheter ablation for drug-refractory paroxysmal atrial fibrillation achieved a single-procedure success rate of 58.7% and a multiprocedure success rate of 86.9% at 12 years.